Metabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patients

dc.contributor.authorO’Connell, Thomas M.
dc.contributor.authorLogsdon, David L.
dc.contributor.authorMitscher, Gloria
dc.contributor.authorPayne, R. Mark
dc.contributor.departmentOtolaryngology -- Head and Neck Surgery, School of Medicineen_US
dc.date.accessioned2023-03-21T12:07:54Z
dc.date.available2023-03-21T12:07:54Z
dc.date.issued2021-10-03
dc.description.abstractBackground: Children and young adults with single ventricle (SV) heart disease frequently develop heart failure (HF) that is intractable and difficult to treat. Our understanding of the molecular and biochemical reasons underlying this is imperfect. Thus, there is an urgent need for biomarkers that predict outcome and provide a rational basis for treatment, and advance our understanding of the basis of HF. Objective: We sought to determine if a metabolomic approach would provide biochemical signatures of HF in SV children and young adults. If significant, these analytes might serve as biomarkers to predict outcome and inform on the biological mechanism(s) of HF. Methods: We applied a multi-platform metabolomics approach composed of mass spectrometry (MS) and nuclear magnetic resonance (NMR) which yielded 495 and 26 metabolite measurements respectively. The plasma samples came from a cross-sectional set of young SV subjects, ages 2-19 years with ten control (Con) subjects and 16 SV subjects. Of the SV subjects, nine were diagnosed as congestive HF (SVHF), and 7 were not in HF. Metabolomic data were correlated with clinical status to determine if there was a signature associated with HF. Results: There were no differences in age, height, weight or sex between the 3 cohorts. However, statistical analysis of the metabolomic profiles using ANOVA revealed 44 metabolites with significant differences between cohorts including 41 profiled by MS and 3 by NMR. These metabolites included acylcarnitines, amino acids, and bile acids, which distinguished Con from all SV subjects. Furthermore, metabolite profiles could distinguish between SV and SVHF subjects. Conclusion: These are the first data to demonstrate a clear metabolomic signature associated with HF in children and young adults with SV. Larger studies are warranted to determine if these findings are predictive of progression to HF in time to provide intervention.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationO'Connell TM, Logsdon DL, Mitscher G, Payne RM. Metabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patients. Metabolomics. 2021;17(10):95. Published 2021 Oct 3. doi:10.1007/s11306-021-01846-8en_US
dc.identifier.urihttps://hdl.handle.net/1805/31988
dc.language.isoen_USen_US
dc.publisherSpringeren_US
dc.relation.isversionof10.1007/s11306-021-01846-8en_US
dc.relation.journalMetabolomicsen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0*
dc.sourcePMCen_US
dc.subjectSingle ventricleen_US
dc.subjectMetabolomicsen_US
dc.subjectHeart failureen_US
dc.subjectBiomarkeren_US
dc.subjectChildrenen_US
dc.titleMetabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patientsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
11306_2021_Article_1846.pdf
Size:
1002.69 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: